SCHEMBL6315903

SCHEMBL6315903

NC(=O)c1c(-c2ccccn2)noc1NS(=O)(=O)c1cccs1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
EDNRA P25101 2/20 0.47
NFKBIA P25963 1/20 0.41
RELA Q04206 1/20 0.41
GLO1 Q04760 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MMP2 P08253 2/20 0.40
TSHR P16473 2/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
ALOX15 P16050 1/20 0.40
OPRK1 P41145 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TLR9 Q9NR96 1/20 0.40
BRAF P15056 2/20 0.40
NPY5R Q15761 1/20 0.40
ALDH1A1 P00352 3/20 0.39
KMT2A Q03164 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6315797 0.90 KDM4E (0.51) KDM4EEDNRANFKBIARELAGLO1
SCHEMBL6317676 0.83 EDNRA (0.46) EDNRAKMT2AGAAMEN1MAPT
SCHEMBL6318219 0.82 EDNRA (0.42) KDM4EEDNRATSHRALDH1A1KMT2A
SCHEMBL6316355 0.82 KDM4E (0.44) KDM4EEDNRATDP1L3MBTL1MMP2
SCHEMBL6317418 0.81 EDNRA (0.47) KDM4EEDNRANFKBIARELAGLO1
SCHEMBL6323782 0.80 EDNRA (0.48) KDM4EEDNRATDP1L3MBTL1TSHR
SCHEMBL6316293 0.78 TDP1 (0.41) EDNRATDP1RET
SCHEMBL6315506 0.77 GLO1 (0.40) KDM4EEDNRAGLO1MMP2ALDH1A1
SCHEMBL6315510 0.77 MEN1 (0.40) EDNRATSHRTP53KMT2AGAA
SCHEMBL6316055 0.76 KDM4E (0.56) KDM4ETDP1L3MBTL1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US claimed
EP-1435948-A1 AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-07-14 EP claimed
WO-2003013517-A1 AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS PHARMACIA ITALIA S.P.A. (IT) 2003-02-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 KDM4E 1382/4885EDNRA 4545/4885NFKBIA 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.